BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35864012)

  • 1. Development and validation of metabolic scoring to individually predict prognosis and monitor recurrence early in gastric cancer: A large-sample analysis.
    Chen QY; Que SJ; Chen JY; Qing-Zhong ; Liu ZY; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Xie JW; Zheng CH; Li P; Huang CM
    Eur J Surg Oncol; 2022 Oct; 48(10):2149-2158. PubMed ID: 35864012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center.
    Zheng ZF; Lu J; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Huang CM
    Ann Surg Oncol; 2017 Jul; 24(7):1795-1803. PubMed ID: 28213789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study.
    Zheng CY; Wu J; Chen CS; Huang ZN; Tang YH; Qiu WW; He QC; Lin GS; Chen QY; Lu J; Wang JB; Lin JX; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM; Zheng YH; Zheng CH
    Eur J Surg Oncol; 2023 Nov; 49(11):107094. PubMed ID: 37797381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative skeletal muscle index vs the controlling nutritional status score: Which is a better objective predictor of long-term survival for gastric cancer patients after radical gastrectomy?
    Zheng ZF; Lu J; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
    Cancer Med; 2018 Aug; 7(8):3537-3547. PubMed ID: 29953752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment value of preoperative platelet-lymphocyte ratio in the prognosis of patients with gastric mixed adenoneuroendocrine carcinoma].
    Cao L; Lu J; Lin J; Zheng C; Li P; Xie J; Wang J; Chen Q; Lin M; Tu R; Huang C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1252-1257. PubMed ID: 27928795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.
    Lin JX; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
    World J Gastroenterol; 2019 Nov; 25(41):6258-6272. PubMed ID: 31749596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-adjusted Charlson Comorbidity Index (ACCI) is a significant factor for predicting survival after radical gastrectomy in patients with gastric cancer.
    Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
    BMC Surg; 2019 May; 19(1):53. PubMed ID: 31133008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
    Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
    JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer].
    Han BL; Wang YM; Xue YW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):65-70. PubMed ID: 31958933
    [No Abstract]   [Full Text] [Related]  

  • 10. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
    Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
    BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
    Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and validation of the prognostic value of nutrition and immunity parameters in gastric cancer after R0 resection.
    Xue W; Xu X; Tan Y; Wang Y; Wang H; Xu Y; Xi C; Jiang P; Ding W
    Medicine (Baltimore); 2020 Feb; 99(8):e19270. PubMed ID: 32080137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy.
    Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
    Eur J Surg Oncol; 2019 Dec; 45(12):2465-2472. PubMed ID: 31350072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of a prognostic nomogram for patients with gastric cancer after radical gastrectomy.
    Hu X; Yang Z; Chen S; Xue J; Duan S; Yang L; Yang P; Peng S; Dong Y; Yuan L; He X; Bao G
    Ann Transl Med; 2021 Dec; 9(23):1742. PubMed ID: 35071436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of surgical treatment of gastric gastrointestinal tumors: a national multi-center retrospective study].
    Feng X; Li R; Zhang P; Chen T; Qiu H; Zhou Y; Du C; Yin X; Pan F; Zheng G; Sun X; Yu J; Chen Z; Zhao Y; Liu X; Li J; Zhang B; Zhou Y; Huang C; Zhou Z; Li G; Tao K; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1258-1264. PubMed ID: 27928796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
    Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and risk factors analysis of lymph node metastasis and long-term prognosis in patients with synchronous multiple gastric cancer.
    Chen L; Yue C; Li G; Ming X; Gu R; Wen X; Zhou B; Peng R; Wei W; Chen H
    World J Surg Oncol; 2021 Jan; 19(1):20. PubMed ID: 33478518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
    Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
    PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.